XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Stockholders' Equity - USD ($)
June 2020 Warrant [Member]
Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
June 2020 Warrant [Member]
Preferred Stock [Member]
Series D Convertible Preferred Stock [Member]
June 2020 Warrant [Member]
Preferred Stock [Member]
Series E Convertible Preferred Stock [Member]
June 2020 Warrant [Member]
Common Stock [Member]
June 2020 Warrant [Member]
Additional Paid-in Capital [Member]
June 2020 Warrant [Member]
Retained Earnings [Member]
June 2020 Warrant [Member]
Warrants Issued Pursuant to 2020 Convertible Debt [Member]
Additional Paid-in Capital [Member]
Warrants Issued Pursuant to 2020 Convertible Debt [Member]
Warrants Issued Pursuant to 2020 Convertible Debt 2 [Member]
Additional Paid-in Capital [Member]
Warrants Issued Pursuant to 2020 Convertible Debt 2 [Member]
Prefunded Warrants [Member]
Common Stock [Member]
Prefunded Warrants [Member]
Additional Paid-in Capital [Member]
Prefunded Warrants [Member]
Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Registered Direct Offerings [Member]
Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Private Placement [Member]
Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
June 2021 Offering [Member]
Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series D Convertible Preferred Stock [Member]
Conversion of Series D Preferred Stock to Common Stock [Member]
Preferred Stock [Member]
Series D Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series E Convertible Preferred Stock [Member]
Series E Preferred Stock Conversions [Member]
Preferred Stock [Member]
Series E Convertible Preferred Stock [Member]
Common Stock [Member]
Registered Direct Offerings [Member]
Common Stock [Member]
Private Placement [Member]
Common Stock [Member]
June 2021 Offering [Member]
Common Stock [Member]
May 2020 Offering [Member]
Common Stock [Member]
Bridge Notes [Member]
Common Stock [Member]
Series E Preferred Stock Conversions [Member]
Common Stock [Member]
Conversion of Series D Preferred Stock to Common Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Registered Direct Offerings [Member]
Additional Paid-in Capital [Member]
Private Placement [Member]
Additional Paid-in Capital [Member]
June 2021 Offering [Member]
Additional Paid-in Capital [Member]
May 2020 Offering [Member]
Additional Paid-in Capital [Member]
Bridge Notes [Member]
Additional Paid-in Capital [Member]
Series E Preferred Stock Conversions [Member]
Additional Paid-in Capital [Member]
Conversion of Series D Preferred Stock to Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Registered Direct Offerings [Member]
Retained Earnings [Member]
Private Placement [Member]
Retained Earnings [Member]
June 2021 Offering [Member]
Retained Earnings [Member]
Registered Direct Offerings [Member]
Private Placement [Member]
June 2021 Offering [Member]
May 2020 Offering [Member]
Bridge Notes [Member]
Total
Balance (in shares) at Dec. 31, 2019                                   79,246   3,500,000   258               4,056,652                                    
Balance at Dec. 31, 2019                                   $ 792   $ 35,000   $ 3               $ 40,567               $ 93,653,667       $ (82,498,711)           $ 11,231,318
Shares issued pursuant to CEO note conversion and accrued interest and exchange agreement (in shares)                                                           1,583,481                                    
Shares issued pursuant to CEO note conversion and accrued interest and exchange agreement                                                           $ 15,835               2,307,043                   2,322,878
Inducement shares issued pursuant to promissory note extension (in shares)                                                           30,000                                    
Inducement shares issued pursuant to promissory note extension                                                           $ 300               40,950                   41,250
Issuance of shares and prefunded warrants pursuant to March 2020 private placement (in shares)                                                           260,000                                    
Issuance of shares and prefunded warrants pursuant to March 2020 private placement                                                           $ 2,600               455,223                   457,823
Inducement shares issued pursuant to 2020 convertible debt and warrants (in shares)                                                           46,875                                    
Inducement shares issued pursuant to 2020 convertible debt and warrants                                                           $ 468               119,532                   120,000
Warrants issued pursuant to 2020 convertible debt               $ 116,951 $ 116,951 $ 62,373 $ 62,373                                                                          
Shares issued pursuant to conversions (in shares)                                   (3,500,000) (258)         170,000 1,398,607 350,004 2,212,359                                    
Shares issued pursuant to conversions                                   $ (35,000) $ (3)         $ 1,700 $ 13,986 $ 3,500 $ 22,124         $ 265,628 $ (13,983) $ 31,500 1,006,230               $ 267,328 1,028,354
Issuance of shares from prefunded warrant exercises (in shares) 1,274,826               1,390,166                             122,000                                    
Issuance of shares from prefunded warrant exercises $ 12,748 $ 1,682,237 $ 1,694,985         $ 13,902 $ (13,149) $ 753                         $ 1,220               190,930                 192,150
Shares issued (in shares)                                                   1,396,826                                            
Issuance of shares                                                   $ 13,968               $ 591,949                       $ 605,917    
Shares issued in connection with asset purchase agreement (in shares)                                                           1,079,719                                    
Shares issued in connection with asset purchase agreement                                                           $ 10,797               1,661,970                   1,672,767
Repricing and Reclassification of warrants issued pursuant to convertible debt $ 803,455 $ 803,455                                                     1,865,953                 1,865,953
Shares issued pursuant to Equity Line (in shares)                                                           4,231,073                                    
Shares issued pursuant to Equity Line                                                           $ 42,311               4,849,037                   4,891,348
Share issuance to consultant and other (in shares)                                                     202,199                                    
Share issuance to consultant and other                                                     $ 2,022               428,184                 430,206
Vesting expense and option repricing                                                                   721,269                 721,269
Net loss                                                                                   (25,884,397)           (25,884,397)
Balance (in shares) at Dec. 31, 2020                                   79,246   0   0               19,804,787                                    
Balance at Dec. 31, 2020                                   $ 792   $ 0   $ 0               $ 198,048               110,826,949       (108,383,108)           2,642,681
Shares issued pursuant to CEO note conversion and accrued interest and exchange agreement (in shares)                                                         400,000                                    
Shares issued pursuant to CEO note conversion and accrued interest and exchange agreement                                                         $ 4,000               (4,000)                 0
Shares issued pursuant to conversions (in shares)                                                         1,107,544                                    
Shares issued pursuant to conversions                                                         $ 11,075               502,936                 514,011
Issuance of shares from prefunded warrant exercises (in shares)                                                           5,269,059                                    
Issuance of shares from prefunded warrant exercises                                                           $ 52,702               4,461,169                   4,513,871
Shares issued (in shares)                                       13,488,098 9,043,766 15,520,911                                              
Issuance of shares                                       $ 134,881 $ 90,438 $ 155,209           $ 14,877,611 $ 15,974,301 $ 19,291,087             $ 15,012,492 $ 16,064,739 $ 19,446,296      
Shares issued pursuant to Equity Line (in shares)                                                         647,504                                    
Shares issued pursuant to Equity Line                                                         $ 6,475               669,115                 675,590
Share issuance to consultant and other (in shares)                                                         174,954                                    
Net loss                                                         $ 0               0       (19,657,174)           (19,657,174)
Balance (in shares) at Dec. 31, 2021                                   79,246                       65,614,597                                    
Balance at Dec. 31, 2021                                   $ 792                       $ 656,146               167,649,028       (128,040,282)           40,265,684
Shares issued pursuant to agreement with former CEO related to accrued interest (in shares)                                                         100,401                                    
Shares issued pursuant to agreement with former CEO related to accrued interest                                                         $ 1,004               142,569                 143,573
Share issuance to consultant and other                                                         $ 1,750               203,443                 205,193
Vesting expense and option repricing (in shares)                                                         57,573                                    
Vesting expense and option repricing                                                         $ 564               $ 703,848                 $ 704,412